BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24033871)

  • 1. The prevalence of onychomycosis in psoriatic patients: a systematic review.
    Klaassen KM; Dulak MG; van de Kerkhof PC; Pasch MC
    J Eur Acad Dermatol Venereol; 2014 May; 28(5):533-41. PubMed ID: 24033871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do fungi play a role in psoriatic nails?
    Szepietowski JC; Salomon J
    Mycoses; 2007 Nov; 50(6):437-42. PubMed ID: 17944702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence, aetiological agents and therapy of onychomycosis in patients with psoriasis: a prospective controlled trial.
    Kaçar N; Ergin S; Ergin C; Erdogan BS; Kaleli I
    Clin Exp Dermatol; 2007 Jan; 32(1):1-5. PubMed ID: 16824053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insight into the pathogenesis of nail psoriasis and overview of treatment strategies.
    Ventura A; Mazzeo M; Gaziano R; Galluzzo M; Bianchi L; Campione E
    Drug Des Devel Ther; 2017; 11():2527-2535. PubMed ID: 28919705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: Results of a pilot study.
    Tsentemeidou A; Vyzantiadis TA; Kyriakou A; Sotiriadis D; Patsatsi A
    Mycoses; 2017 Dec; 60(12):830-835. PubMed ID: 28877373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of culture-confirmed toenail onychomycosis in at-risk patient populations.
    Gupta AK; Daigle D; Foley KA
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1039-44. PubMed ID: 25413984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased prevalence of onychomycosis among psoriatic patients in Israel.
    Leibovici V; Hershko K; Ingber A; Westerman M; Leviatan-Strauss N; Hochberg M
    Acta Derm Venereol; 2008; 88(1):31-3. PubMed ID: 18176747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onychomycosis in psoriatic patients - rationalization of systemic treatment.
    Shemer A; Trau H; Davidovici B; Grunwald MH; Amichai B
    Mycoses; 2010 Jul; 53(4):340-3. PubMed ID: 19496936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fungal infections and nail psoriasis].
    Solovăstru LG; Vâţă D
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1083-8. PubMed ID: 20191878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Incidence of fungal involvement in nail psoriasis].
    Ständer H; Ständer M; Nolting S
    Hautarzt; 2001 May; 52(5):418-22. PubMed ID: 11405160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onychomycosis in patients with psoriasis--a multicentre study.
    Zisova L; Valtchev V; Sotiriou E; Gospodinov D; Mateev G
    Mycoses; 2012 Mar; 55(2):143-7. PubMed ID: 21771106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of onychomycosis in psoriatic nails: a descriptive study.
    Natarajan V; Nath AK; Thappa DM; Singh R; Verma SK
    Indian J Dermatol Venereol Leprol; 2010; 76(6):723. PubMed ID: 21079333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of onychomycosis and nail psoriasis and its correlation with systemic treatment.
    Grynszpan R; Barreiros G; do Nascimento Paixão M; Frasnelli Fernandes M; Aguinaga F; Camargo C; Ramos-E-Silva M; Carneiro S
    Mycoses; 2021 Sep; 64(9):1092-1097. PubMed ID: 34061419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review and meta-analysis on the epidemiology, casual agents and demographic characteristics of onychomycosis in Iran.
    Rafat Z; Hashemi SJ; Saboor-Yaraghi AA; Pouragha B; Taheriniya A; Moosavi A; Roohi B; Arjmand R; Moradi A; Daie-Ghazvini R; Basiri S
    J Mycol Med; 2019 Sep; 29(3):265-272. PubMed ID: 31285126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoronychomycosis: A New Term for an Old Problem.
    Vender R; Vender R
    J Cutan Med Surg; 2016 May; 20(3):279-80. PubMed ID: 26992422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with onychomycosis in nail psoriasis: a multicenter study in Pakistan.
    Tabassum S; Rahman A; Awan S; Jabeen K; Farooqi J; Ahmed B; Masood S; Memon M; Rashid A; Soomro MR; Samdani AJ; Naveed S; Kapadia N
    Int J Dermatol; 2019 Jun; 58(6):672-678. PubMed ID: 30615189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nail dystrophy in psoriatic arthritis presenting as nail onychomycosis: a case report.
    Kim JY; Baek GH; Gong HS
    Hand Surg; 2012; 17(1):139-42. PubMed ID: 22351553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of onychomycosis in patients with psoriasis and other skin diseases.
    Larsen GK; Haedersdal M; Svejgaard EL
    Acta Derm Venereol; 2003; 83(3):206-9. PubMed ID: 12816157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence and etiological factors of onychomycosis in psoriatic patients.
    Romaszkiewicz A; Bykowska B; Zabłotna M; Sobjanek M; Sławińska M; Nowicki RJ
    Postepy Dermatol Alergol; 2018 Jun; 35(3):309-313. PubMed ID: 30008651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onychomycosis in Psoriatic Patients with Nail Disorders: Aetiological Agents and Immunosuppressive Therapy.
    Alves NCPOP; Moreira TA; Malvino LDS; Rodrigues JJ; Ranza R; de Araújo LB; Pedroso RDS
    Dermatol Res Pract; 2020; 2020():7209518. PubMed ID: 32411192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.